Transperineal MRI-Guided Fusion Biopsy
Transperineal MR Fusion Biopsy: A Next-Generation Method for Prostate Cancer Diagnosis
Introduction
Prostate cancer is one of the most common types of cancer among men, and early diagnosis is critical for successful treatment. While traditional prostate biopsies have been performed for years via the rectal route (TRUS—transrectal ultrasound-guided), advanced techniques have come to the forefront in recent years to improve indications, efficacy, and patient comfort. One such advancement is the Transperineal MR Fusion Biopsy.
Transperineal MR Fusion Biopsy is a modern method that offers high sensitivity in the diagnosis of prostate cancer. This technique is performed by combining (fusing) magnetic resonance imaging (MRI) with ultrasound images, enabling the collection of an accurate tissue sample by specifically targeting high-risk or suspicious lesions.
In this article, we will comprehensively cover all aspects of transperineal MR fusion biopsy—from its scientific foundations to the details of its application, and from its advantages to its risks.
- Prostate Cancer and the Diagnostic Process
1.1 What Is Prostate Cancer?
The prostate is an important part of the male reproductive system and surrounds the initial portion of the urinary tract. Prostate cancer is a malignant tumor that originates in the cells of this organ. While most prostate cancers progress slowly, some types can be more aggressive.
The diagnosis of prostate cancer is usually:
- The PSA (Prostate-Specific Antigen) test,
- Digital rectal examination (DRE),
- Imaging methods (MRI, ultrasound),
- Biopsy
is placed with.
1.2 The Relationship Between PSA and Biopsy
PSA is a protein produced by the prostate, and PSA levels in the blood may rise in the presence of prostate cancer. However, a high PSA level does not always indicate cancer; conditions such as infection or benign prostatic hyperplasia (BPH) can also raise PSA levels. For this reason, a PSA test alone is not diagnostic. To confirm the diagnosis, a tissue sample must be taken—this is called a biopsy.
- Traditional Biopsy Methods and Their Limitations
2.1 Transrectal Ultrasonography (TRUS) Biopsy
For many years, prostate biopsies have been performed transrectally under ultrasound guidance. In this method:
- The ultrasound probe is inserted into the rectum,
- The prostate is visualized,
- 10–12 tissue samples are taken from random locations.
2.2 What Are the Problems with TRUS?
The TRUS biopsy has some significant limitations:
✔ Diagnostic sensitivity is low (especially in aggressive cancers)
✔ Imaging-based targeting is poor
✔ The risk of false-negative results is high due to random sampling
✔ The risk of infection is higher
✔ Patients may experience pain and discomfort
These limitations have made it necessary to use a more targeted and precise biopsy technique.
- What Is Transperineal MR Fusion Biopsy?
Transperineal MR Fusion Biopsy is one of the most advanced methods developed for detecting prostate cancer. It essentially consists of three key components:
- Multiparametric Prostate MRI (mpMRI)
- Fusion Technology (Combination of MRI and Ultrasound)
- Transperineal Approach
3.1 Multiparametric Prostate MRI (mpMRI)
mpMR provides high-resolution images of the prostate and identifies clinically suspicious areas. mpMR results are reported using the PIRADS (Prostate Imaging – Reporting & Data System) scoring system; high PIRADS scores indicate a higher likelihood of cancer.
3.2 Fusion Technology
In fusion biopsy;
- Images obtained from mpMR
- Ultrasound images are combined using software
This allows suspicious areas to be targeted under ultrasound guidance, resulting in more accurate tissue samples.
3.3 Transperineal Approach
In a transperineal biopsy, the needle is guided into the prostate through the perineum—the area between the groin and the testicles. This procedure is performed without touching the rectum.
- Transperineal vs. Transrectal Biopsy
4.1 Risk of Infection
In a transrectal biopsy, the risk of infection is higher because the needle is contaminated with rectal bacteria. For this reason, antibiotic prophylaxis is necessary. In the transperineal approach, this risk is significantly reduced.
4.2 Diagnostic Sensitivity
Transperineal MRI-Guided Fusion Biopsy;
✔ Because it takes samples from the targeted lesions
✔ Because it clearly identifies suspicious areas with mpMR
✔ Because it can better assess deeper and zonal regions
The sensitivity of cancer diagnosis is higher.
4.3 Pain and Comfort
Transperineal biopsy can be performed comfortably using modern anesthesia techniques (sedation/local block). Additionally, this method provides more reliable results when a repeat biopsy is necessary.
- Advantages of Transperineal MR Fusion Biopsy
5.1 High Diagnostic Accuracy
mpMR-targeted samples provide more accurate results by avoiding unnecessary random sampling.
5.2 Fewer False Negatives
Cancer foci that may be missed in random TRUS biopsies are more easily detected with MR-guided biopsy.
5.3 Low Risk of Infection
The perineal region is a “cleaner” area than the rectum in terms of bacterial load. For this reason, serious infections are rare.
5.4 Application Area Width
Transperineal MRI-Guided Fusion Biopsy;
- Initial diagnostic biopsy
- Repeat biopsy (for patients with suspicious PSA or MRI findings)
- In cases requiring monitoring (active monitoring)
It can be a good choice in many situations like this.
5.5 Clarity for Clinicians
MR–ultrasound fusion-guided targeting provides the surgeon with clear, mapped information about the lesion's location.
- For Which Patients Is It Used?
Transperineal MRI-guided biopsy is generally recommended for patients in the following situations:
📌 Those with elevated PSA levels
📌 Those with suspicious lesions identified on mpMRI (PIRADS 3–5)
📌 Those in whom cancer was not detected in a previous biopsy but for whom suspicion persists
📌 Recurrent elevated PSA levels
📌 Patients in an active surveillance program
- Pre-Biopsy Evaluation
The preparations to be made before a transperineal MR fusion biopsy are as follows:
7.1 PSA Test and Digital Rectal Exam
The decision to perform a biopsy is typically based on parameters such as PSA level, PSA density, and specific PSA. The consistency of the prostate is assessed through a digital rectal exam.
7.2 mpMR Imaging
Multiparametric MRI is essential for biopsy planning. The PIRADS score derived from these images determines the biopsy targets.
7.3 Use of Medications and Antibiotics
Since the risk of infection is lower with the transperineal approach, the need for standard antibiotics may be more limited; however, antibiotics may be initiated according to the clinical protocol.
- What Happens During a Biopsy?
8.1 Anesthesia
The procedure is usually performed under sedation, local anesthesia, or light general anesthesia. This is important for the patient's comfort.
8.2 Imaging and Fusion
- mpMR images are uploaded to specialized software
- Real-time images from the ultrasound probe are synchronized with MRI images
- Suspicious areas are targeted
8.3 Tissue Collection Procedure
Tissue samples are collected from the targeted areas using specialized biopsy needles. These samples are sent to the pathology laboratory.
- Pathology and Evaluation of Results
Biopsy samples are examined by a pathologist, and the results typically include the following parameters:
📍 Presence/absence of cancer
📍 Gleason score / ISUP group
📍 Tumor rate
📍 Invasion characteristics
This information directly influences the decision regarding treatment.
- Potential Risks and Side Effects of Transperineal Biopsy
As with any invasive procedure, there are certain risks:
10.1 Infection
The risk of infection is minimal with the transperineal approach.
10.2 Bleeding
Minor bleeding at the surgical site is rare.
10.3 Pain or Discomfort
Since the procedure is performed under anesthesia, pain is minimal; there may be some temporary sensitivity afterward.
10.4 Urinary Problems
Temporary difficulty urinating may occur, but it is not permanent.
- The Future of Transperineal MR Fusion Biopsy
Medical technologies are advancing rapidly, and transperineal MRI-guided fusion biopsy is increasingly becoming the gold standard in this field. Combined with artificial intelligence, advanced imaging software, and robot-assisted biopsy systems, this technique will become even more precise. By preserving healthy tissue and targeting only cancerous areas, it will significantly improve treatment planning.
- Conclusion
Transperineal MR Fusion Biopsy is a revolutionary method for diagnosing prostate cancer. It delivers significantly better results than traditional biopsy methods, offering higher diagnostic accuracy, a lower risk of infection, and targeted sampling. It is an ideal option, particularly for patients with suspicious mpMR findings or those who have previously received a negative biopsy result.
Frequently Asked Questions (FAQ)
Q1: Is a transperineal MR fusion biopsy painful?
Generally, no. It is performed under local anesthesia or sedation, and patients have a comfortable experience during the procedure.
Q2: How long is the recovery period after the procedure?
Most patients can resume their normal activities the same day. Mild tenderness subsides quickly.
S3: When will the results be available?
Pathology results are usually ready within 7–10 business days.
Q4: How is a treatment plan determined?
Based on the results, the treatment team develops a plan; follow-up, surgery, radiation therapy, or other treatments may be considered.